Zobrazeno 1 - 2
of 2
pro vyhledávání: '"R. M. Bijlsma"'
Autor:
M. Opdam, V. van der Noort, M. Kleijn, A. Glas, I. Mandjes, S. Kleiterp, F. S. Hilbers, D. T. Kruger, A. D. Bins, P. C. de Jong, P. P. J. B. M. Schiphorst, T. van Dalen, B. Flameling, R. C. Rietbroek, A. Beeker, S. M. van den Heiligenberg, S. D. Bakker, A. N. M. Wymenga, I. M. Oving, R. M. Bijlsma, P. J. van Diest, J. B. Vermorken, H. van Tinteren, S. C. Linn
Publikováno v:
Breast cancer research and treatment, 194(2), 265-278. Springer New York
Breast cancer research and treatment
Breast Cancer Research and Treatment, 194(2), 265-278. Springer New York
Opdam, M, van der Noort, V, Kleijn, M, Glas, A, Mandjes, I, Kleiterp, S, Hilbers, F S, Kruger, D T, Bins, A D, de Jong, P C, Schiphorst, P P J B M, van Dalen, T, Flameling, B, Rietbroek, R C, Beeker, A, van den Heiligenberg, S M, Bakker, S D, Wymenga, A N M, Oving, I M, Bijlsma, R M, van Diest, P J, Vermorken, J B, van Tinteren, H & Linn, S C 2022, ' Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature ', Breast Cancer Research and Treatment, vol. 194, no. 2, pp. 265-278 . https://doi.org/10.1007/s10549-022-06618-z
Breast cancer research and treatment
Breast Cancer Research and Treatment, 194(2), 265-278. Springer New York
Opdam, M, van der Noort, V, Kleijn, M, Glas, A, Mandjes, I, Kleiterp, S, Hilbers, F S, Kruger, D T, Bins, A D, de Jong, P C, Schiphorst, P P J B M, van Dalen, T, Flameling, B, Rietbroek, R C, Beeker, A, van den Heiligenberg, S M, Bakker, S D, Wymenga, A N M, Oving, I M, Bijlsma, R M, van Diest, P J, Vermorken, J B, van Tinteren, H & Linn, S C 2022, ' Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature ', Breast Cancer Research and Treatment, vol. 194, no. 2, pp. 265-278 . https://doi.org/10.1007/s10549-022-06618-z
Purpose Guidelines recommend endocrine treatment for estrogen receptor-positive (ER+) breast cancers for up to 10 years. Earlier data suggest that the 70-gene signature (MammaPrint) has potential to select patients that have an excellent survival wit
Autor:
D P, Staal, C, Vlooswijk, F, Mols, E, Lidington, W T A, van der Graaf, R M, Bijlsma, O, Husson
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 29(1)
Insight into the causes of colorectal cancer (CRC) in adolescent and young adult (AYA) patients is limited. Without definitive information, patients often shape their own beliefs on the cause of their illness, developing causal attributions. This stu